Welcome to The Myeloma Minutes.  We've now moved to a fortnightly release schedule, so you can now hear us every-other Thursday. This episode explores bispecific antibodies — how they work, the benefits they bring, and the key side effects patients and carers need to know about. 📌Key Takeaways: Bispecific antibodies ‘wake up’ your immune system to fight myeloma — and response rates are higher than ever before. Early side effects (like fever or low blood pressure) usually settle quickly with the right care. Infections are the main long-term risk — but regular antibody infusions and vigilance make treatment much safer. This podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised medical guidance regarding your health concerns   ABOUT YOUR HOSTS Dr. Jam Kothari Dr Jam Kothari (@myeloma_medic) is an Oxford based blood cancer doctor, specialising in the treatment of multiple myeloma and associated conditions. He has been a consultant for a decade, and leads the provision of myeloma care for Oxford and neighbouring areas. He lectures regionally and nationally and leads clinical trials investigating the use of new treatments for myeloma. He is a strong believer in patient based, holistic care, delivered with warmth, clarity and integrity.   Dr. Sally Moore Dr Sally Moore is a Bristol based consultant who specialises in treating patients living with multiple myeloma and other plasma cell disorders. She oversees the delivery of clinical research studies for myeloma patients and has academic interests in how to maximise quality of life for patients and improve outcomes in older, less fit patients.  She frequently contributes to myeloma related educational events for fellow doctors and healthcare professionals at a local, regional and national level and is an active member of the UK Myeloma Research Alliance and an executive member of the UK Myeloma Society.